STELLA, LEONARDO
 Distribuzione geografica
Continente #
AS - Asia 514
NA - Nord America 343
EU - Europa 324
AF - Africa 45
SA - Sud America 37
OC - Oceania 3
Totale 1.266
Nazione #
US - Stati Uniti d'America 308
IT - Italia 180
BD - Bangladesh 163
SG - Singapore 96
CN - Cina 89
DE - Germania 68
VN - Vietnam 63
EG - Egitto 35
IN - India 33
HK - Hong Kong 28
BR - Brasile 24
FR - Francia 22
CA - Canada 14
MX - Messico 14
NL - Olanda 13
JP - Giappone 11
PL - Polonia 11
GB - Regno Unito 8
ES - Italia 5
PK - Pakistan 5
IQ - Iraq 4
RO - Romania 4
TR - Turchia 4
AU - Australia 3
CO - Colombia 3
EC - Ecuador 3
GT - Guatemala 3
HU - Ungheria 3
KR - Corea 3
UA - Ucraina 3
ZA - Sudafrica 3
AR - Argentina 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
ID - Indonesia 2
IE - Irlanda 2
KE - Kenya 2
KG - Kirghizistan 2
MA - Marocco 2
MY - Malesia 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
JM - Giamaica 1
JO - Giordania 1
LT - Lituania 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 1.266
Città #
Ashburn 68
Frankfurt am Main 62
San Jose 48
Singapore 31
Hong Kong 28
New York 23
Ho Chi Minh City 21
Rome 21
Al Mansurah 20
Los Angeles 16
Kolkata 15
Buffalo 13
Cairo 13
Hanoi 13
Hillsboro 12
Boardman 10
Milan 10
Tokyo 10
Beijing 9
Naples 9
Dallas 8
Toronto 8
Mexico City 7
Warsaw 7
Amsterdam 6
Orem 6
Verona 6
Bari 4
Bologna 4
Chennai 4
Genoa 4
Indore 4
Limburg an der Lahn 4
Madrid 4
Budapest 3
Council Bluffs 3
Da Nang 3
Florence 3
Lucca 3
Palermo 3
Phủ Lý 3
Santa Clara 3
Bishkek 2
Brisbane 2
Bắc Giang 2
Bắc Ninh 2
Can Tho 2
Catania 2
Charlotte 2
Faisalabad 2
Fresno 2
Karachi 2
Newark 2
Oakland 2
Pasadena 2
Philadelphia 2
Portsmouth 2
Queens 2
São Paulo 2
Taboão da Serra 2
Wroclaw 2
Abu Dhabi 1
Aga 1
Ahmedabad 1
Alto Araguaia 1
Amman 1
Andria 1
Apizaco 1
Apple Valley 1
Bacau 1
Baghdad 1
Bahía Blanca 1
Baku 1
Bangkok 1
Banjar Badung 1
Barranquilla 1
Belford Roxo 1
Bogotá 1
Botoșani 1
Bremerton 1
Brescia 1
Bridgewater 1
Bucharest 1
Buckeye 1
Bursa 1
Cagliari 1
Campo Belo 1
Cape Town 1
Caracas 1
Casablanca 1
Castel San Giovanni 1
Chaguanas 1
Chandigarh 1
Changsha 1
Chiclayo 1
Cochabamba 1
Colima 1
Columbus 1
Cubatão 1
Danbury 1
Totale 629
Nome #
PO5-18-YI Predictors of esophago-gastric varices and variceal bleeding in patients receiving atezolizumab/bevacizumab for unresectable hepatocellular carcinoma 68
PO5-12-YI Outcomes and safety of DAA treatment in HCV cirrhotic patients treated with Atezolizumab-Bevacizumab for hepatocellular carcinoma 59
OP034 LIVER DECOMPENSATION AS A NEW OUTCOME AND PROGNOSTIC INDICATOR IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH ATEZOLIZUMAB PLUS BEVACIZUMAB: A REAL-LIFE MULTICENTER STUDY 56
Thrombotic Risk and Coagulation Imbalance in Cirrhosis and Hepatocellular Carcinoma: Clinical Implications and Management 48
PO3-23-YI The changing epidemiology of patients with HCC receiving a first-line systemic therapy: insights from ARPES and ARTE databases (2008- 2024) 47
PO6-11 Statins in patients with advanced HCC treated with atezolizumab/bevacizumab: a propensity score-matched cohort analysis from ARTE an Italian prospective multicentric dataset 46
PO4-03-YI Efficacy and safety of atezoliumab/bevacizumab for hepatocellular carcinoma in a real-world prospective cohort: a 2024 update 45
PP0819 HEPATITIS C TREATMENT IMPROVES ONCOLOGIC OUTCOMES IN PATIENTS RECEIVING ATEZOLIZUMAB PLUS BEVACIZUMAB 44
Manuale di malattie infettive e microbiologia. SSM 2026 42
Cancer Vaccines: A Promising Therapeutic Strategy in Advanced Solid Tumors 38
Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis 37
COVID-19 atypical Parsonage-Turner syndrome: a case report 37
Autobrewery Syndrome and Endogenous Ethanol Production in Patients with MASLD: A Perspective from Chronic Liver Disease 36
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study 34
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 33
Angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID‐19 32
Malnutrition in COVID-19 survivors: prevalence and risk factors 27
Intestinal Inflammation and Permeability in Patients Recovered from SARS-CoV-2 Infection 26
Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab 26
Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey 24
COVID-19 and intestinal inflammation: Role of fecal calprotectin 24
PO7-09-YI Does AtezoBev present as a safe and efficacious treatment option for hepatocellular carcinoma in patients with Child-Pugh B cirrhosis? A retrospective multicentric real-world study 24
OC.03.3 COMPARATIVE ANALYSIS OF ATEZOBEV’S THERAPEUTIC EFFICACY IN ADVANCED HEPATOCELLULAR CARCINOMA AMONG NON-CIRRHOTIC PATIENTS: FINDINGS FROM A RETROSPECTIVE MULTICENTER STUDY 23
Functional hypothalamic amenorrhea: gut microbiota composition and the effects of exogenous estrogen administration 22
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 21
Outcomes and safety of DAA treatment in HCV cirrhotic patients treated with Atezolizumab- Bevacizumab for hepatocellular carcinoma 21
Assessment of neurological manifestations in hospitalized patients with COVID‐19 20
Predicting In‐Hospital Mortality in COVID‐19 Older Patients with Specifically Developed Scores 17
Persistent Symptoms in Patients After Acute COVID-19 16
Liver involvement is not associated with mortality: results from a large cohort of SARS‐CoV‐2‐positive patients 16
Management of Portal Hypertension in Patients with Hepatocellular Carcinoma on Systemic Treatment: Current Evidence and Future Perspectives 16
Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment 16
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 16
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 16
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19 15
Manuale di malattie infettive e microbiologia. Concorso Nazionale SSM 15
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab 15
Can AtezoBev be a safe and effective option for treating hepatocellular carcinoma in patients with Child-Pugh B cirrhosis? A retrospective multicenter real-world study 15
Liver cirrhosis in the Emergency Department: a change of paradigm in DAAs era 13
Hepatocellular-Carcinoma-Derived Organoids: Innovation in Cancer Research 12
THU-492 Prognostic significance of liver decompensation, liver function and portal hypertension in cirrhotic patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab 12
Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications 12
Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers 12
The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence 12
Promising PD-1 antagonists for liver cancer: an evaluation of phase II and III results 11
Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive 11
Neuropsychological Measures of Long COVID-19 Fog in Older Subjects 11
Liver Decompensation in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Real-life Study 11
Heparanase-1 and MMPs in Covid-19 and non-Covid-19 pneumonia 11
Immunotherapy for the treatment of hepatocellular carcinoma: finally in clinical practice 10
Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection 10
The diagnosis of neglected tropical diseases (NTDs) in Italy: reply 9
Peripapillary Retinal Vascular Involvement in Early Post-COVID-19 Patients 8
Residual respiratory impairment after COVID-19 pneumonia 8
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 7
Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study 7
Spectrum and burden of neglected tropical diseases observed in an infectious and tropical diseases unit in Florence, Italy (2000–2015) 7
Neuropsychological measures of post-COVID-19 cognitive status 6
Seroprevalence of anti‐SARS‐CoV‐2 IgG antibodies in children with household exposure to adults with COVID‐19: Preliminary findings 5
Totale 1.338
Categoria #
all - tutte 4.970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.970


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/20261.338 0 0 0 0 266 121 67 158 129 201 163 233
Totale 1.338